These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8632551)

  • 1. Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: a study of satisfaction and safety.
    Limoge JP; Olins E; Henderson D; Donatucci CF
    J Urol; 1996 Apr; 155(4):1276-9. PubMed ID: 8632551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
    Soderdahl DW; Thrasher JB; Hansberry KL
    Br J Urol; 1997 Jun; 79(6):952-7. PubMed ID: 9202565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.
    Chen J; Godschalk MF; Katz PG; Mulligan T
    J Urol; 1995 May; 153(5):1476-7. PubMed ID: 7714970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
    Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N
    J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers.
    Watanabe T; Chancellor MB; Rivas DA; Hirsch IH; Bennett CJ; Finocchiaro MV; Razi S; Bennett JK; Green BG; Foote JE; Killorian RW; Juma S; Linsenmeyer TA; Lloyd K
    J Spinal Cord Med; 1996 Jul; 19(3):186-9. PubMed ID: 8819027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction.
    Gheorghiu S; Godschalk M; Gentili A; Mulligan T
    J Urol; 1996 Jul; 156(1):80-1. PubMed ID: 8648844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy.
    Mulhall JP; Daller M; Traish AM; Gupta S; Park K; Salimpour P; Payton TR; Krane RJ; Goldstein I
    J Urol; 1997 Nov; 158(5):1752-8; discussion 1758-9. PubMed ID: 9334594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R; Mohamed K; Akhras AA; Rashwan H
    Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The external vacuum device in the management of erectile dysfunction.
    Opsomer RJ; Wese FX; De Groote P; Van Cangh PJ
    Acta Urol Belg; 1997 Dec; 65(4):13-6. PubMed ID: 9497591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances.
    Moemen MN; Hamed HA; Kamel II; Shamloul RM; Ghanem HM
    Int J Impot Res; 2004 Apr; 16(2):143-5. PubMed ID: 15014552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
    Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
    J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.